BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21163759)

  • 21. [Ifosfamide-induced nephrotoxicity].
    Rossi R; Rath B; Ullrich K; Ehrich JH
    Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients.
    Launay-Vacher V; Izzedine H; Rey JB; Rixe O; Chapalain S; Nourdine S; Paci A; Bourget P; Deray G
    Med Sci Monit; 2004 May; 10(5):CR209-12. PubMed ID: 15114271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors.
    Lagrange JL; Médecin B; Etienne MC; Pivot X; Cassuto-Viguier E; Renée N; Thyss A; Ferrero JM; Otto J; François E; Milano G
    Pharmacotherapy; 1997; 17(6):1246-53. PubMed ID: 9399607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anticancer drug-induced nephrotoxicity].
    Isnard-Bagnis C; Moulin B; Launay-Vacher V; Izzedine H; Tostivint I; Deray G
    Nephrol Ther; 2005 May; 1(2):101-14. PubMed ID: 16895673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002.
    Hotta K; Takigawa N; Hisamoto-Sato A; Ichihara E; Kudo K; Uchida K; Yanase-Nakamura K; Tanaka H; Kato Y; Tabata M; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2013 Nov; 43(11):1115-23. PubMed ID: 24082005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kidney function in oncologic patients after cisplastin chemotherapy].
    Hozhenko AI; Moskalenko OM; Sirman VM; ZhiZhnievs'ka OO; Storozhenko SA
    Fiziol Zh (1994); 2012; 58(3):72-6. PubMed ID: 22946315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.
    Ogilvie GK; Fettman MJ; Jameson VJ; Walters LM; Lafferty MH; Cooper MF; Powers BE; Ciekot PA; Atwater SW; Withrow SJ
    Am J Vet Res; 1992 Sep; 53(9):1666-9. PubMed ID: 1416374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
    Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
    Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
    Ahn JH; Kang YK; Kim TW; Bahng H; Chang HM; Kang WC; Kim WK; Lee JS; Park JS
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):104-10. PubMed ID: 12172973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
    Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anesthetic management and renal function in pediatric patients undergoing cytoreductive surgery with continuous hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin.
    Owusu-Agyemang P; Arunkumar R; Green H; Hurst D; Landoski K; Hayes-Jordan A
    Ann Surg Oncol; 2012 Aug; 19(8):2652-6. PubMed ID: 22451231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity.
    Sánchez-González PD; López-Hernández FJ; López-Novoa JM; Morales AI
    Crit Rev Toxicol; 2011 Nov; 41(10):803-21. PubMed ID: 21838551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989).
    Ogilvie GK; Straw RC; Powers BE; Cooper MF; Withrow SJ
    J Am Vet Med Assoc; 1991 Sep; 199(5):613-6. PubMed ID: 1787122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.
    Dash A; Galsky MD; Vickers AJ; Serio AM; Koppie TM; Dalbagni G; Bochner BH
    Cancer; 2006 Aug; 107(3):506-13. PubMed ID: 16773629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
    Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
    Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
    Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
    Hinai Y; Motoyama S; Niioka T; Miura M
    J Clin Pharm Ther; 2013 Dec; 38(6):498-503. PubMed ID: 24102360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
    Pili-Floury S; Royer B; Bartholin F; Crumiere N; Combe M; Chalopin JM; Pivot X; Heyd B; Chauffert B; Samain E
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):199-203. PubMed ID: 21306815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal effects of low dose aspirin in elderly patients.
    Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
    Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.